Skip to content

A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04675476
Enrollment
368
Registered
2020-12-19
Start date
2024-03-11
Completion date
2026-02-28
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.

Detailed description

The proposed study will target two key levels of influence in the healthcare setting: provider and patient behavior in order to address disparities between African American and whites in lung screening awareness and utilization. Guided by NIH's Health Disparities Research Framework and building on the formative work conducted in the K99 phase, we will conduct a quasi-experimental study (pretest-posttest, with a nonequivalent control group) in partnership with four primary care clinics within the MedStar Health system in the R00 phase.

Interventions

BEHAVIORALProvider Prompt & Patient Outreach and Education

To target lack of provider-prompted discussion about lung screening, an electronic medical record (EMR) message will be sent to primary care providers prior to scheduled visits with screening-eligible patients to notify them of the patient's eligibility and to encourage discussion of the benefits and limitations of the test. To target patient-level knowledge about lung screening, an outreach specialist will educate screening-eligible patients about the benefits and limitations of the test prior to their visit.

Sponsors

Georgetown University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* 50-80 years old; * current cigarette smoker or quit within 15 years; * a 20+ pack-year smoking history; * non-adherent to lung screening (\>13 months); * English-speaking; * scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and * able and willing to provide meaningful consent and complete telephone interviews

Exclusion criteria

* Individuals with a history of lung cancer

Design outcomes

Primary

MeasureTime frameDescription
provider-patient discussion1-week post-visitDiscussion about lung screening with the provider ('did you have a discussion with your doctor about lung screening?')
lung cancer screening intentions1-week post-visitScreening intentions ('how likely is it that you will undergo lung screening in the next 6-months?')
lung cancer screening knowledge1-week post-visitLung cancer screening knowledge measure

Secondary

MeasureTime frameDescription
lung cancer screening referrals6-monthsTotal number of lung screening orders captured via the electronic medical record
lung cancer screening completion rates6-monthsTotal number of lung screening completions captured via the electronic medical record

Countries

United States

Contacts

Primary ContactRandi M Williams, PhD
rmw27@georgetown.edu(202) 687-7036

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026